Zandelisib Active Not Recruiting Phase 2 Trials for indolent B-cell non-Hodgkin Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04533581Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)